tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Income Statement

Compare
172 Followers

Pharming Group Income Statement

Last quarter (Q3 2025), Pharming Group's total revenue was $97.29M, an increase of 29.98% from the same quarter last year. In Q3, Pharming Group's net income was $7.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 297.20M$ 245.32M$ 205.62M$ 198.87M$ 212.17M
Gross Profit
$ 261.80M$ 220.10M$ 188.06M$ 177.73M$ 188.63M
Operating Expenses
$ 270.42M$ 225.49M$ 169.83M$ 164.17M$ 112.38M
Depreciation and Amortization
$ 16.07M$ 15.93M$ 13.19M$ 19.61M$ 8.31M
EBITDA
$ 16.32M$ 9.88M$ 33.53M$ 48.78M$ 58.35M
Operating Income
$ -8.62M$ -5.39M$ 18.23M$ 13.56M$ 76.26M
Other Income/Expenses
$ 129.00K$ -6.63M$ -3.25M$ 9.52M$ -32.16M
Pretax Income
$ -8.49M$ -12.01M$ 14.99M$ 23.08M$ 44.09M
Net Income
$ -11.84M$ -10.55M$ 13.67M$ 16.00M$ 37.75M
Per Share Metrics
Basic EPS
$ -0.17$ -0.14$ 0.17$ 0.20$ 0.47
Diluted EPS
$ -0.17$ -0.14$ 0.16$ 0.18$ 0.47
Weighted Average Shares Outstanding
68.92M 65.70M 82.54M 87.64M 79.88M
Weighted Average Shares Outstanding (Diluted)
68.92M 65.70M 84.28M 87.64M 80.98M
Currency in USD

Pharming Group Earnings and Revenue History